Folgen
-
Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs to provide an update on the status of Congressional funding legislation and ASN's advocacy priorities. This episode mainly focuses on the House Appropriations Committee.
-
Hosts Tod Ibrahim and David White discuss the recently released CY2025 End-Stage Renal Disease Prospective Payment System and Quality Incentive Program (ESRD PPS QIP) proposed rule and the CY2025 Medicare Physician Fee Schedule proposed rule.
-
Fehlende Folgen?
-
Hosts Tod Ibrahim and David White discuss the Center for Medicare and Medicaid Innovation's recently announced Increasing Organ Transplant Access (IOTA) Model proposed rule.
-
Hosts Tod Ibrahim and David White are joined by colleague Zach Kribs, ASN Manager of Congressional Affairs to discuss ASN's recent Capitol Hill advocacy on transplant.
-
David White is joined by Health Policy Scholar in Residence Dr. Suzanne Watnick and Zach Kribs to discuss the Kidney PATIENT Act of 2023- a bill that would delay the inclusion oral only drugs in the ESRD PPS.
-
Quality and Regulatory Affairs Associate Lauren Ahearn is joined by Congressional Affairs Manager Zach Kribs to discuss the possible March partial government shutdown as well as congressional action on the Medicare physician reimbursement cut.
-
Hosts Tod Ibrahim and David White welcome longtime ASN policy strategist and attorney Andrew Shore from JST Strategies, LLC to discuss SCOTUS's upcoming decision in Relentless vs. Department of Commerce and its potential impact on federal rulemaking.
-
Join hosts Tod Ibrahim and David White to discuss Congress' recent passage of a stop-gap budget bill and the Center for Medicare & Medicaid's prior authorizations final rule.
-
Congressional Affairs Manager Zach Kribs joins hosts Tod Ibrahim and David White to discuss what to expect this year in both federal regulatory and Congressional health care policy.
-
In this episode, discover what Nisha Bansal, MD, FASN, and Ankur Shah, MD, FASN, consider this year's highlights. They will dive into Kidney Week highlights, community interactions, and kidney health.
-
In this episode, Raad Bin Zakir Chowdhury, MD, FASN, and Deepak Chandramohan, MD, discuss their experiences with the evolving directions and tools for kidney care treatment with Angie S. Lobo, MD, moderating the conversation.
-
In this episode, George L. Bakris, MD, MA, FASN, and Duc H. Quach, MD, discuss day 2 of Kidney Week.
-
In this episode, Joel M. Topf, MD, hosts the discussion with Jennie Lin, MD, MS, FASN and patient advocate, Precious McCowan, MS, as they dive into experiences with kidney disease and the key takeaways from the Early Program sessions.
-
David White and Lauren Ahearn interview colleagues Zach Kribs and Rachel Meyer about HRSA's OPTN Modernization Initiative and H.R. 2544. Contact HRSA about the OPTN Modernization Initiative here- https://www.hrsa.gov/optn-modernization/contact
-
With the start of summer comes the start of the busy policy season. Tod Ibrahim, David White, and Lauren Ahearn discuss the recent SCOTUS decision on affirmative action, the CY2024 ESRD PPS QIP proposed rule, and ASN's upcoming Transplant Advocacy Day.
-
In this Regulatory and Legislative update David White and Tod Ibrahim discuss Medicaid redetermination, concurrent dialysis and hospice, and the case of Braidwood Management vs. Becerra.
-
David White speaks with ASN President Michelle A. Josephson, MD, FASN, and ASN Strategic Policy Advisor to the Executive Vice President Rachel Meyer about changes within HRSA, big-picture issues within transplant nephrology, and more.
-
In this episode, Tod and David discuss recent updates from within the Department of Health and Human Services, including changes in the OPTN, the back-and-forth between the FDA and CMS on the accelerated approval of drugs, and more.
-
In this episode, David speaks with Zach Kribs, ASN Manager of Congressional Affairs, on Kidney Community Advocacy Day, ASN's goals for Hill Day 2023, Congressional priorities in 2023, the debt ceiling, and more.
- Mehr anzeigen
